| MeSH term | MeSH ID | Detail |
|---|---|---|
| Body Weight | D001835 | 333 associated lipids |
| Colonic Neoplasms | D003110 | 161 associated lipids |
| Edema | D004487 | 152 associated lipids |
| Prostatic Neoplasms | D011471 | 126 associated lipids |
| Inflammation | D007249 | 119 associated lipids |
| Hypertension | D006973 | 115 associated lipids |
| Glioma | D005910 | 112 associated lipids |
| Weight Gain | D015430 | 101 associated lipids |
| Insulin Resistance | D007333 | 99 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
Anandamide
Anandamide is a lipid of Fatty Acyls (FA) class. Anandamide is associated with abnormalities such as Dehydration. The involved functions are known as Process, Phenomenon, Phosphorylation, Catabolic Process and Gene Expression. Anandamide often locates in Nuchal region, Microglial and Hepatic. The associated genes with Anandamide are SGPL1 gene, SPTLC1 gene, RPSA gene, KDSR gene and SMPD1 gene. The related lipids are Sphingolipids, Lipopolysaccharides, Lysophospholipids, LYSO-PC and lysophosphatidylethanolamine.
Cross Reference
Introduction
To understand associated biological information of Anandamide, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Anandamide?
Anandamide is suspected in Dehydration and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Anandamide
PubChem Associated disorders and diseases
What pathways are associated with Anandamide
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Anandamide?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Anandamide?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Anandamide?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Anandamide?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Anandamide?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Anandamide
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Deutsch DG and Chin SA | Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. | 1993 | Biochem. Pharmacol. | pmid:8373432 |
| Mackie K et al. | Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoma cells. | 1993 | Mol. Pharmacol. | pmid:8371711 |
| Johnson DE et al. | Isolation, identification and synthesis of an endogenous arachidonic amide that inhibits calcium channel antagonist 1,4-dihydropyridine binding. | 1993 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:8341720 |
| Pertwee RG et al. | Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. | 1993 | Br. J. Pharmacol. | pmid:8306090 |
| Bornheim LM et al. | The effect of cannabidiol on mouse hepatic microsomal cytochrome P450-dependent anandamide metabolism. | 1993 | Biochem. Biophys. Res. Commun. | pmid:8267610 |
| Kruszka KK and Gross RW | The ATP- and CoA-independent synthesis of arachidonoylethanolamide. A novel mechanism underlying the synthesis of the endogenous ligand of the cannabinoid receptor. | 1994 | J. Biol. Chem. | pmid:8182035 |
| Devane WA | New dawn of cannabinoid pharmacology. | 1994 | Trends Pharmacol. Sci. | pmid:8165721 |
| Childers SR et al. | Effects of anandamide on cannabinoid receptors in rat brain membranes. | 1994 | Biochem. Pharmacol. | pmid:8129747 |
| Weidenfeld J et al. | Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. | 1994 | Neuroendocrinology | pmid:8127398 |
| Wickens AP and Pertwee RG | delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats. | 1993 | Eur. J. Pharmacol. | pmid:8119321 |
| Koutek B et al. | Inhibitors of arachidonoyl ethanolamide hydrolysis. | 1994 | J. Biol. Chem. | pmid:8083191 |
| Schuel H et al. | Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. | 1994 | Proc. Natl. Acad. Sci. U.S.A. | pmid:8052642 |
| Smith PB et al. | The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. | 1994 | J. Pharmacol. Exp. Ther. | pmid:8035318 |
| Devane WA and Axelrod J | Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. | 1994 | Proc. Natl. Acad. Sci. U.S.A. | pmid:8022836 |
| Di Marzo V et al. | Formation and inactivation of endogenous cannabinoid anandamide in central neurons. | 1994 | Nature | pmid:7990962 |
| Iversen L | Pharmacology. Endogenous cannabinoids. | 1994 | Nature | pmid:7990950 |
| Mechoulam R et al. | Search for endogenous ligands of the cannabinoid receptor. | 1994 | Biochem. Pharmacol. | pmid:7980618 |
| Schwarz H et al. | Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. | 1994 | J. Neuroimmunol. | pmid:7962480 |
| Van der Kloot W | Anandamide, a naturally-occurring agonist of the cannabinoid receptor, blocks adenylate cyclase at the frog neuromuscular junction. | 1994 | Brain Res. | pmid:7953630 |
| Crawley JN et al. | Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. | 1993 | Pharmacol. Biochem. Behav. | pmid:7906042 |
| Desarnaud F et al. | Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. | 1995 | J. Biol. Chem. | pmid:7890734 |
| Wartmann M et al. | The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide. | 1995 | FEBS Lett. | pmid:7867785 |
| Fride E et al. | Low doses of anandamides inhibit pharmacological effects of delta 9-tetrahydrocannabinol. | 1995 | J. Pharmacol. Exp. Ther. | pmid:7853184 |
| Hillard CJ et al. | Characterization of ligand binding to the cannabinoid receptor of rat brain membranes using a novel method: application to anandamide. | 1995 | J. Neurochem. | pmid:7830060 |
| Ueda N et al. | Lipoxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist. | 1995 | Biochim. Biophys. Acta | pmid:7827116 |
| Welch SP et al. | Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception. | 1995 | J. Pharmacol. Exp. Ther. | pmid:7791096 |
| Adams IB et al. | Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. | 1995 | J. Pharmacol. Exp. Ther. | pmid:7791088 |
| Edgemond WS et al. | The binding of novel phenolic derivatives of anandamide to brain cannabinoid receptors. | 1995 Feb-Mar | Prostaglandins Leukot. Essent. Fatty Acids | pmid:7784462 |
| Wiley J et al. | Discriminative stimulus effects of anandamide in rats. | 1995 | Eur. J. Pharmacol. | pmid:7781695 |
| Cabral GA et al. | Anandamide inhibits macrophage-mediated killing of tumor necrosis factor-sensitive cells. | 1995 | Life Sci. | pmid:7776833 |
| Wenger T et al. | Effects of anandamide (endogen cannabinoid) on anterior pituitary hormone secretion in adult ovariectomized rats. | 1995 | Life Sci. | pmid:7776832 |
| Adams IB et al. | Pharmacological and behavioral evaluation of alkylated anandamide analogs. | 1995 | Life Sci. | pmid:7776830 |
| Romero J et al. | The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons. | 1995 | Life Sci. | pmid:7776829 |
| Omeir RL et al. | Arachidonoyl ethanolamide-[1,2-14C] as a substrate for anandamide amidase. | 1995 | Life Sci. | pmid:7776824 |
| Musty RE et al. | A review of recent advances in cannabinoid research and the 1994 International Symposium on Cannabis and the Cannabinoids. | 1995 | Life Sci. | pmid:7776816 |
| Fan P | Cannabinoid agonists inhibit the activation of 5-HT3 receptors in rat nodose ganglion neurons. | 1995 | J. Neurophysiol. | pmid:7760148 |
| Das SK et al. | Cannabinoid ligand-receptor signaling in the mouse uterus. | 1995 | Proc. Natl. Acad. Sci. U.S.A. | pmid:7753807 |
| Koga D et al. | High-performance liquid chromatography and fluorometric detection of arachidonylethanolamide (anandamide) and its analogues, derivatized with 4-(N-chloroformylmethyl-N-methyl)amino-7-N,N-dimethylaminosulp honyl-2,1 ,3- benzoxadiazole (DBD-COCl). | 1995 Jan-Feb | Biomed. Chromatogr. | pmid:7734936 |
| Ueda N et al. | Oxygenation of arachidonylethanolamide (anandamide) by lipoxygenases. | 1995 | Adv. Prostaglandin Thromboxane Leukot. Res. | pmid:7732825 |
| Facci L et al. | Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. | 1995 | Proc. Natl. Acad. Sci. U.S.A. | pmid:7724569 |
| Pertwee RG et al. | Effect of phenylmethylsulphonyl fluoride on the potency of anandamide as an inhibitor of electrically evoked contractions in two isolated tissue preparations. | 1995 | Eur. J. Pharmacol. | pmid:7713152 |
| Burstein SH and Hunter SA | Stimulation of anandamide biosynthesis in N-18TG2 neuroblastoma cells by delta 9-tetrahydrocannabinol (THC). | 1995 | Biochem. Pharmacol. | pmid:7702643 |
| Munro S et al. | Molecular characterization of a peripheral receptor for cannabinoids. | 1993 | Nature | pmid:7689702 |
| Romero J et al. | Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. | 1995 | Pharmacol. Biochem. Behav. | pmid:7675852 |
| Di Marzo V and Fontana A | Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. | 1995 | Prostaglandins Leukot. Essent. Fatty Acids | pmid:7675818 |
| Bornheim LM et al. | Microsomal cytochrome P450-mediated liver and brain anandamide metabolism. | 1995 | Biochem. Pharmacol. | pmid:7669071 |
| Priller J et al. | Mead ethanolamide, a novel eicosanoid, is an agonist for the central (CB1) and peripheral (CB2) cannabinoid receptors. | 1995 | Mol. Pharmacol. | pmid:7651362 |
| Hillard CJ et al. | Characterization of the kinetics and distribution of N-arachidonylethanolamine (anandamide) hydrolysis by rat brain. | 1995 | Biochim. Biophys. Acta | pmid:7647100 |
| Venance L et al. | Inhibition by anandamide of gap junctions and intercellular calcium signalling in striatal astrocytes. | 1995 | Nature | pmid:7637807 |
| Mechoulam R et al. | Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. | 1995 | Biochem. Pharmacol. | pmid:7605349 |